ArticleScientific reports2025
Computational study of the therapeutic properties of allicin and its nanocomplexes using DFT and molecular docking techniques.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Cytotoxic Activity and In Silico Study of Secondary Metabolites Derived fromMarine drugs · 2026Article
- Therapeutic potential of allicin against viral infections: Mechanisms and safety profile (Review).Experimental and therapeutic medicine · 2026Review
- Modeling and experimental insight into the electronic and structural properties of Sodium alginate/Polypyrrole/Titanium dioxide nanocomposites.Scientific reports · 2026Article
- Thienopyrimidine scaffolds as promising antimicrobial agents: synthesis, biological evaluation, DFT analysis and molecular docking.RSC advances · 2026Article
- Rational design of cisplatin and carboplatin complexes for enhanced anticancer efficacy based on DFT QTAIM and docking analyses.Scientific reports · 2026Article
- First-Principles Modeling of Nitazoxanide Analogues as Prospective PFOR-Targeted Antibacterials.International journal of molecular sciences · 2025Article
- Cracking the Sulfur Code: Garlic Bioactive Molecules as Multi-Target Blueprints for Drug Discovery.Pharmaceuticals (Basel, Switzerland) · 2025Review
- DFT and molecular docking study of curcumin interactions with aflatoxins m1 and M2 at processing temperatures for reducing toxicity in milk and dairy products.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated the anti-inflammatory, anticancer, antiviral, and antibacterial effects of allicin and its complexes (Allicin/C₂₄, Allicin/B₁₂N₁₂, and Allicin/Al₁₂N₁₂) using advanced computational techniques such as Density Functional Theory (DFT), Quantum Theory of Atoms in Molecules (QTAIM), and molecular docking. The interactions were analyzed in two phases: gas and aqueous. Results revealed that the Allicin/Al₁₂N₁₂ complex exhibited the highest adsorption energy (Ead = -44.43 kcal/mol in the gas phase) and thermodynamic stability (ΔH = -44.36 kcal/mol, ΔG = -29.19 kcal/mol). QTAIM analysis revealed that the Allicin/C₂₄ complex involves very weak noncovalent interactions, the Allicin/B₁₂N₁₂ complex shows weak covalent bonding with considerable ionic character; and the Allicin/Al₁₂N₁₂ complex exhibits stronger covalent interactions with significant electron density sharing. The Allicin/Al₁₂N₁₂ complex showed a reduced energy gap (3.44 eV) and higher reactivity than free allicin (5.42 eV). Molecular docking demonstrated that this complex had the strongest binding affinity with biological targets, such as HER2, TNF-α, COVID-19 main protease, and Staphylococcus aureus. UV-Vis and IR spectroscopy revealed significant electronic and vibrational modifications in the complexes, particularly Allicin/Al₁₂N₁₂. These findings suggest that nanocages, especially Al₁₂N₁₂, can significantly enhance the stability, bioavailability, and therapeutic potential of allicin. The Allicin/Al₁₂N₁₂ complex, with its strong binding affinity and favorable electronic properties, has emerged as a promising candidate for treating cancer, inflammation, bacterial infections, and COVID-19. This study highlights the importance of natural products in drug discovery and the role of computational methods in understanding complex biological interactions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.